FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036950 [Registered on: 29/09/2021] Trial Registered Prospectively
Last Modified On: 28/09/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive
Screening 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparative effectiveness of Jyotishmati and Yastimadhu granules in improving IQ and memory in school-aged children with various prakriti- A randomised, double blind clinical trial 
Scientific Title of Study   Evaluation of comparative efficacy of Jyotishmati and Yastimadhu granules in enhancing IQ and memory in school going children having different prakriti A double blind randomized clinical trail 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ibamedabha Japang 
Designation  PG scholar 
Affiliation  PG Student  
Address  Mahatma Gandhi Ayurved College Hospital And Research Centre Salod Wardha
Mahatma Gandhi Ayurved College Hospital And Research Centre Salod Wardha
Wardha
MAHARASHTRA
442001
India 
Phone  8073804823  
Fax    
Email  ibjapang@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Renu Rathi 
Designation  Professor 
Affiliation  Professor and Head Department of Kaumarbhritya MGACH & RC  
Address  Mahatma Gandhi Ayurveda College Hospital And Research Center salod Wardha
Aditya Resedency Yavatmal Road Sawangi meghe Wardha
Wardha
MAHARASHTRA
442001
India 
Phone  9373703816  
Fax    
Email  renu.rathi@dmimsu.edu.in  
 
Details of Contact Person
Public Query
 
Name  Ibamedabha Japang 
Designation  PG scholar 
Affiliation  PG Student Department of Kumarbhritya  
Address  Mahatma Gandhi Ayurved College Hospital And Research Center salod Wardha
Near Mahatma Gandhi Ayurveda college Neri, Punarvasan Salod (H) Wardha 442001
Wardha
MAHARASHTRA
442001
India 
Phone  08073804823  
Fax    
Email  ibjapang@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurveda College Hospital And Research Centre salod Wardha 
 
Primary Sponsor  
Name  Ibamedabha Japang 
Address  Mahatma Gandhi Ayurveda College Hospital And Research Centre salod Wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Mahatma Gandhi Ayurveda College Hospital And Research Centre  Mahatma Gandhi Ayurveda College Hospital And Research Centre salod Wardha 442001 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ibamedabha Japang  DMIMS Deemed to be University  Department of Kaumarbhritya Mahatma Gandhi Ayurveda Hospital And Research Centre salod, Wardha 442001
Wardha
MAHARASHTRA 
8073804823

ibjapang@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Children of dominant vataj, pittaj, kaphaj prakriti. 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Yastimadhu, Reference: Charaka, sushrut, Vagbhat, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Milk), Additional Information:
2Intervention ArmDrugClassical(1) Medicine Name: jyotishmati, Reference: raj nigantu, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -milk), Additional Information:
 
Inclusion Criteria  
Age From  8.00 Year(s)
Age To  13.00 Year(s)
Gender  Both 
Details  children whose parents are willing to participate and signed the informed consent.
children of dominant vataj, pittaj, kaphaj. 
 
ExclusionCriteria 
Details  children with subnormal intelligence or having diagnosed mental illness.
children suffering any acute or chronic illness and or taking medicine. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of jyotishmati on IQ and memory with different prakriti types  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Yastimadhu on IQ and memory with different prakriti types  2 months 
 
Target Sample Size   Total Sample Size="65"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   11/10/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study will be randomized, standard controlled double blind , parallel group clinical study on healthy volunteer children between 8-13 years.

in Group 1 will be given Jyotishmati granules in dose as per age in two divided dose with milk. While Goup 2 will be given Yastimadhu granules in dose as per age in  two divided dose. Granules will be made of study drug i.e Yastimadhu and Jyotishmati, With use of jaggery and cow ghee. The drug will be given continuously for 60 days.


 
Close